A Three-part First-in-human Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GUB-UCN2 in Healthy Lean and Obese Participants and Participants With T2D
Clinical trial NCT07702890 · RECRUITING
Trial details
- NCT number
- NCT07702890
- Sponsor
- Gubra A/S
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-12-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.